Infographic: Two Pain Paths Diverge in the Body

The acute pain that results from injury or disease is very different from chronic pain.

Dec 31, 2017
Mark R. Hutchinson


Persistent pain continues even after the damage is resolved, or in some cases, in the absence of an acute injury in the first place. The difference between this and acute pain, also known as nociception, researchers are learning, comes down to the neural mechanisms that trigger these distinct signals in the brain.

Acute pain is caused by the activation of nociceptive sensory neurons in the periphery. These neurons trigger the firing of a series of connected somatosensory neurons up the spinal cord and into the brain, transferring information about the intensity and duration of the painful stimulus.

Persistent pain
Pain that persists long after or in the absence of injury can result from the misfiring of the normal nociceptive pathway. This can be triggered in the periphery—sometimes arising from a neutral stimulus, such as light touch—with the signal becoming amplified on its way to the brain. Alternatively, persistent pain can arise in the absence of any stimulus with the firing of neurons in spinal cord or brain circuits responsible for pain processing. Immune-like cells of the central nervous system known as glia are now recognized to contribute to the aberrant neural activation that causes persistent pain.

Glia’s Role in Persistent Pain

Microglia release cytokines and other proinflammatory molecules, as well as detect signaling factors from peripheral immune cells (1). Together, these signals can enhance the release of excitatory neurotransmitters from pain-transmitting neurons, leading to increased neuronal firing (2). Normally, when glial cells called astrocytes detect an increase in the extracellular concentrations of neurotransmitters, their cellular processes called endfeet begin to take up greater amounts of the molecules in an attempt to bring the hyperactive synapses under control (3). In persistent pain, these cells contain fewer of the molecular transporters responsible for this neurotransmitter removal. Glial cytokines and chemokines can also cause greater numbers of receptors to be displayed on the postsynaptic terminal of the pain-transmitting synapse, further promoting neuroexcitability (4).


Read the full story.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets


Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!